Arcadia Biosciences Stock Forecast

Buy candidate since Jun 05, 2026

The Arcadia Biosciences stock price gained 3.88% on the last trading day (Friday, 5th Jun 2026), rising from $1.03 to $1.07. During the last trading day the stock fluctuated 14.89% from a day low at $0.94 to a day high of $1.08. The price has risen in 7 of the last 10 days and is up by 18.11% over the past 2 weeks. Volume fell on the last day by -132 thousand shares and in total, 0 shares were bought and sold for approximately $0 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.15 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -46.94% during the next 3 months and, with a 90% probability hold a price between $0.285 and $0.613 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

RKDA Signals & Forecast

The Arcadia Biosciences stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.99 and $1.04. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 01, 2026, and so far it has risen 16.76%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Arcadia Biosciences stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.95 and $0.92. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Arcadia Biosciences finds support just below today's level at $0.95. If this is broken, then the next support from accumulated volume will be at $0.92 and $0.91.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.140 between high and low, or 14.89%. For the last week the stock has had daily average volatility of 9.54%

Our recommended stop-loss: $1.04 (-3.22%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 4 days ago.)

Trading Expectations (RKDA) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Arcadia Biosciences to open at $1.03, and during the day (based on 14 day Average True Range), to move between $1.01 and $1.13, which gives a possible trading interval of +/-$0.122 (+/-12.08%) up or down from last closing price. If Arcadia Biosciences takes out the full calculated possible swing range there will be an estimated 12.08% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.12 (4.67%) than the support at $0.95 (11.51%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Arcadia Biosciences stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.719 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $1.03 ( 3.74%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk